Dechra Veterinary Products extends its otitis range with the addition of DuOtic® (terbinafine and betamethasone acetate otic gel)

Friday, March 29, 2024

Dechra Veterinary Products is pleased to announce the expansion of its range of products to treat otitis externa with the addition of DuOtic® (terbinafine and betamethasone acetate otic gel).

DuOtic^® is indicated for the treatment of otitis externa in dogs, associated with susceptible strains of yeast (Malassezia pachydermatis).

DuOtic^® should be administered in the clinic. Administer one dose (1 tube) per affected ear(s) and repeat administration in 7 days. It is the same dose for any dog, regardless of size and weight and is easy to administer from a pre-measured, single-dose tube helping to ensure the right dose every time. It also has a flexible, soft tip that is gentle on a dog’s ears.

DuOtic^® is the latest addition to Dechra’s broad dermatology portfolio that includes Osurnia^® (florfenicol, terbinafine, betamethasone acetate) Otic Gel, Animax^® Ointment (nystatin, neomycin sulfate, thiostrepton, triamcinolone acetonide ointment), and Mometavet^® (gentamicin sulfate, mometasone furoate anhydrous, and clotrimazole otic suspension).

Mike Eldred, President of North America Operations, commented: “We understand otitis externa is a common challenge for both veterinarians and clients, with ear infections among the most frequent reasons dogs are taken to the veterinarian. Dechra is excited to add DuOtic^® to our expansive dermatology portfolio and offer veterinarians an option to practice antimicrobial stewardship when managing canine otitis.”

The product will be available for veterinarians to purchase through select veterinary distributors in the near future.

Dechra’s companion animal portfolio focuses on endocrinology, anesthesia/analgesia, oncology, dermatology, kidney health, ophthalmology, fluid therapy, anti-infectives, joint health, and dental care.

Our key dermatology brands include topical products such as MiconaHex+Triz^®, TrizCHLOR 4^®, Atopivet^® and Malaseb^® branded products; a range of ear cleaners and flushes including TrizULTRA+Keto^® Flush, MalAcetic ULTRA^® Ear Cleanser and EpiKlean^® Ear Cleanser; and supplements such as Redonyl^® Ultra Soft Chews and Eicosa3FF^® SnipCaps Omega 3 Free Fatty Acid Capsules.

Important Safety Information
As with all drugs, side effects may occur. For Otic Use in Dogs Only. Do not use in cats. Do not use in dogs with known tympanic perforation. Do not use in dogs with a hypersensitivity to terbinafine or corticosteroids. Do not administer orally. Use with caution in dogs with impaired hepatic function. In a field study and post-approval experience following the use of a similar product Osurnia^® (florfenicol, terbinafine, betamethasone acetate) the most common adverse reactions were elevated alanine aminotransferase, conjunctivitis, ocular discharge, ear pruritus, deafness, ear discharge, pinnal irritation and ear pain, emesis, head shaking, internal ear disorder (head tilt and vestibular), ataxia, vocalization, corneal ulcer, keratoconjunctivitis sicca, nystagmus, tympanic rupture, and cranial nerve disorder (facial paralysis). The safe use of DuOtic^® has not been evaluated in dogs that are pregnant, lactating or intended for breeding. DuOtic^® may cause eye injury and irritation. DuOtic^® should be administered by a veterinary professional. Wear eye protection when administering DuOtic^® and restrain the dog to minimize post- application head shaking. Refer to the prescribing information for complete details or visit www.dechra-us.com.